SCHEMBL3277257

SCHEMBL3277257

COc1cc(O)c(OC)c2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 10/20 0.61
▸ MAPT P10636 9/20 0.61
▸ MEN1 O00255 9/20 0.61
▸ ALDH1A1 P00352 7/20 0.61
▸ TDP1 Q9NUW8 3/20 0.61
▸ KDM4E B2RXH2 2/20 0.61
▸ USP2 O75604 1/20 0.61
▸ DUSP3 P51452 1/20 0.61
▸ RAB9A P51151 4/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ EGFR P00533 1/20 0.54
▸ PIM1 P11309 1/20 0.54
▸ THRB P10828 2/20 0.54
▸ LCK P06239 1/20 0.54
▸ GLA P06280 1/20 0.54
▸ LIMK1 P53667 1/20 0.54
▸ LIMK2 P53671 1/20 0.54
▸ MAOA P21397 1/20 0.52
▸ POLB P06746 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19461410 0.87 MAPT (0.61) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL12581679 0.85 MAPT (0.64) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL8996244 0.82 MAPT (0.62) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL28916427 0.81 KMT2A (0.79) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL8996410 0.80 MAPT (0.56) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL23043842 0.80 MAPT (0.66) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL9522230 0.78 MAPT (0.57) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL1426442 0.78 SMN1; SMN2 (0.70) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL29906115 0.78 SMN1; SMN2 (0.70) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL9177114 0.77 MAPT (0.54) KMT2AMAPTMEN1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691418-B2 Composition for inhibiting or preventing the formation of a biofilm OYSTERSHELL NV (BE) 2010-04-06 — — US disclosed
US-20070258913-A1 Composition for Inhibiting or Preventing the Formation of a Biofilm OYSTERSHELL NV (BE) 2007-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258913-A1 Composition for Inhibiting or Preventing the Formation of a Biofilm NQO2, NFKBIA, CROCC KMT2A 3594/4885MAPT 4695/4885MEN1 3614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback